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Abstract The solution conformation of conantokin-T, a Gla-
containing 21-residue peptide, (GiEYyYsQKMLyLoNLRyA]^-
EVKKN2oA-amide), in the absence of divalent metal ions, was 
studied by use of two-dimensional proton NMR spectroscopy. 
The peptide is helical from the N-terminus to the C-terminus, as 
defined by upfield-shifted ot-proton resonances and by character-
istic NOE connectivities. Extensive interactions among the 
aniino acid side-chains were identified from the NOESY spectra 
of this peptide in a buffered aqueous solution. Four hydrophobic 
residues Tyr5, Met8, Leu9, and Leu12 contact one another in a 
stable cluster, even in the presence of 6 M urea. The solution 
structure of conantokin-T is a well-defined a-helix, having 
RMSD values for the backbone and all heavy atoms of 0.40 A 
and 0.77 A, respectively. Potential repulsion between the 
negatively-charged side chains of Gla10 and Gla14 is minimized 
by a Gln8-Gla10 hydrogen bond and by an Arg13-Gla14 ion-pair 
interaction. The C-terminal amide and the Asn20 side-chain 
amide both interact with the backbone and minimize fraying at 
the C-terminal end of the a-helix. This study provides a basis to 
evaluate the changes in peptide conformation concomitant upon 
the binding of divalent metal ions. In addition, this investigation 
demonstrates that apo-conantokin-T has almost all of the 
favorable interactions that are known to contribute to helical 
stabilization in proteins and monomeric helices. 
© 1997 Federation of European Biochemical Societies. 
Key words: Conantokin-T; Peptide folding; NMDA 
receptor; Helical polypeptides; gwwwza-Carboxyglutamate 
1. Introduction 
The survival and proliferation of snails belonging to the 
genus Conus is due to the development of remarkable peptide 
warfare that they inflict on their prey, competitors, and pred-
ators [1]. The venom of the cone snail, which is injected 
through a disposable chitin-containing harpoon, consists of 
a diverse array of bioactive peptides which are typically 10-
30 amino acids in length [2]. Structural rigidity appears to 
play a key role in the activity of these peptides. In particular, 
the conotoxins are a class of multiple disulfide-containing 
molecules that interact with nicotinic acetylcholine receptors 
(a-conotoxins), voltage-sensitive sodium channels (co-conotox-
ins) and voltage-sensitive calcium channels (u-conotoxins) [1]. 
The conantokins are Gla-containing peptides which have been 
shown to function as antagonists of the mammalian gluta-
mate/glycine receptors of the 7V-methyl-D-aspartic acid 
(NMDA) subclass [3]. The NMDA receptor forms a cell-
*Corresponding author. Fax: (1) (514) 496-5143. 
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membrane ion channel that controls the flux of Ca2+ and Na+ 
into nerve cells. The receptor is activated only if Gly and Glu 
bind in concert and polyamines assist in the opening or clos-
ing of the ion channel, depending on their concentration. The 
action of conantokin-G (con-G) and presumably conantokin-
T (con-T) has been attributed to the inhibition of the positive 
modulatory effects of polyamines [4]. When a stroke occurs, a 
detrimental influx of calcium initiates a cascade of events that 
eventually lead to neuronal cell death. Therefore, elucidating 
the mechanisms of NMDA antagonists and developing potent 
molecules to attenuate Ca2+ influx are the focus of intense 
research efforts. 
Presumably, structural stabilization in the conantokin pep-
tides is facilitated through calcium-chelation by the Gla resi-
dues [1,5]. In particular, apo-con-G was found to have very 
little helical content in aqueous solution, but it becomes al-
most completely helical ( > 85%) upon binding to calcium ions 
[5]. The conantokin-T peptide is also highly helical in the 
presence of calcium ions [1,3,5]. We recently investigated the 
calcium-binding properties of con-G (17-mer) and con-T (21-
mer) by circular dichroism (CD) and potentiometry [6]. We 
proposed that divalent cation binding to con-T and con-G, 
chiefly to Gla residues contained in the peptides, is responsible 
for providing an active conformation that is able to interact 
with high affinity to its receptor site. Interestingly, at 25°C, 
apo-con-G has essentially no helical content ( ~ 0%) in aque-
ous solution but con-T exhibits a significant helical character 
( > 40%) in the absence of divalent metal ions. We report here 
the solution structure of the conantokin-T peptide in the ab-
sence of divalent metal ions and under near neutral pH con-
ditions. A detailed structure of apo-con-T will aid in the 
elucidation of the roles of metal binding in the bio-
logical activities of conantokin peptides. It also provides 
further evidence for the numerous interactions governing 
the conformational stability of helical peptides in the ab-
sence of disulfide bonds, metal ions or helix-inducing solvents 
[7]. 
2. Materials and methods 
2.1. Sample preparation 
The conantokin-T peptide was prepared by Fmoc chemistry on an 
Applied Biosystems (Foster City, CA) Model 433A Peptide Synthe-
sizer and purified as described previously [6]. The peptide was dis-
solved in 10 mM sodium borate/100 mM NaCl to a final concentra-
tion of 2 mM. A volume of 50 ul of 2H20 was added to 450 ul of the 
peptide solution to provide the NMR deuterium lock signal. 4,4-Di-
methyl-4-silapentane-l-sulfonate (DSS) was added as an internal 
reference. The pH of the sample was adjusted with dilute HC1 to 
6.5 to minimize the loss of NH signals at higher pH values. Lowering 
the pH value from our previous CD investigation (pH 8.0) had no 
significant effect on the molar residue ellipticity values at 222 nm. 
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2.4. Structure calculations 
Peptide conformations free from steric overlaps and consistent with 
the NMR data were generated by distance geometry (DG) calcula-
tions utilizing the fixed bond lengths and bond angles provided in the 
ECEPP/3 database [17]. Optimization was achieved through a variable 
target function (VTF) implementation of distance geometry concepts, 
by varying all dihedral angles except for the a> angles governing the 
planarity of the peptide plane [18-20], The set of backbone and side-
chain dihedral angles were considered as independent variables during 
minimization of a distance target function or the ECEPP/3 potential 
energy [18,19]. Assigned NOE crosspeaks were characterized as 
strong, medium, or weak as determined from the number ofcontours 
and converted to distance upper bounds of 2.7, 3.7 and 5.0 A, respec-
tively. All side-chain to side-chain or side-chain to backbone medium 
range (;', i+2, i, i"+3 and i, z+4) distance constraints were set to upper 
bounds of 5.0 A, except for the [daN(i, i+3)] and [dap(/, i+3)] NOEs 
which were uniformly set to 3.7 A (Table 2). The side chains of Asp, 
Glu, and Gla were treated as charged groups, Lys and Arg as neutral 
residues, and the hydrogen-bonding potentials of the Gin, Asn, Lys 
and Arg side-chains were eliminated during NOE distance-constrained 
energy minimization. In addition, charge interactions were screened 
by use of a sinusoidal distance-dependent dielectric function [20]. 
These empirical treatments of electrostatic interactions served to avoid 
potential bias of the computed NMR conformations by dominating 
electrostatic or hydrogen-bonding terms in the ECEPP force field. 
Further refinement of the peptide structures were carried out by dis-
tance-restrained Monte Carlo energy minimization [21]. Some over-
lapped NOEs were assigned based on the model structures generated 
from well-resolved NOE constraints. Remaining NOEs that could not 
be assigned uniquely were considered as ambiguous constraints that 
take into account all possible NOE interactions in an unbiased man-
ner [19,20]. 
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Fig. 1. Expanded view of the aromatic zone of a 250 ms NOESY 
spectrum of con-T at 5°C. Vertical lines dissect the NOE crosspeaks 
from the Arg13 guanidino protons, in addition to Val17 methyl pro-
tons and a |3Hof Gla10. 
2.2. NMR 
One- and two-dimensional NMR experiments were carried out on a 
Bruker AMX2-500 and/or DRX-500 spectrometer using procedures as 
described previously [8,9]. TOCSY [10,11], flip-back NOESY [12] and 
DQF-COSY [13] spectra were acquired at 5, 15, and 25°C without 
spinning the sample. NOESY experiments were collected with mixing 
times of 150 and 250 ms. Spectral processing was carried out using 
FELIX (Hare Research) and an in-house program, nmrDSP, on Sil-
icon Graphics workstations. Spectral contrast-enhancement methods 
were applied to resolve severely overlapped proton resonances [14,15]. 
The Sybyl software package (TRIPOS, Inc.) was used for spectral 
vizualization. 
2.3. Proton resonance assignments 
Sequence-specific assignments of the proton resonances for apo-
con-T were achieved by combining the procedures of spin system 
identification using TOCSY, followed by sequential assignments 
through NOE connectivities [16]. The guanidino protons (H11) of 
Arg13 were identified as a pair of moderately-broad signals in the 
NOESY spectra at 15°C and 5°C. Consistent with this assignment 
are the absence of TOCSY peaks but the presence of NOESY peaks, 
from the guanidino protons to all of the Arg13 side-chain and back-
bone protons. In particular, medium-strength NOEs are observed 
from the Arg13 guanidino protons to the eNH and 8CH2 protons 
(Fig. 1). In addition, the eNH of Arg13 exhibits an uncharacteristic 
downfield shift (7.72 ppm). All chemical shift values were determined 
from the 2D spectra and reported with respect to the DSS signal 
which was set to 0 ppm (Table 1). 
Table 1 
Proton resonance assignments of conantokin-T at 5°Ca 
Residue Chemical shift (ppm) 
NH aCH 6CH Others 
Gly1 
Glu2 
Gla3 
Gla4 
Tyr5 
Gin6 
Lys7 
Met8 
Leu9 
Gla10 
Asn11 
Leu12 
Arg13 
9.13 
9.21 
8.07 
8.11 
8.16 
7.71 
7.75 
7.88 
8.09 
8.24 
8.04 
7.87 
Gla14 
Ala15 
Glu16 
Val17 
Lys18 
Lys19 
Asn20 
Ala21 
Amide cap 
8.23 
7.99 
7.74 
7.81 
7.94 
7.92 
8.09 
7.80 
3.80, 
4.07 
3.96 
3.89 
4.21 
3.71 
3.90 
3.99 
3.77 
3.95 
4.33 
3.99 
3.92 
3.92 
4.00 
3.94 
3.61 
3.97 
3.95 
4.48 
4.07 
3.94 
1.93* 
2.03* 
2.21, 2.31 
2.96, 3.05 
2.00* 
1.73* 
2.30, 2.54 
1.22* 
2.05, 2.23 
2.82, 2.69 
1.42* 
1.73, 1.83 
2.07, 2.13 
1.36 
1.98* 
2.08 
1.73* 
1.71* 
2.62, 2.72 
1.30 
7CH2 2.21* 
•yCH 3.06 
7CH 3.05 
7.01; 
2.37* 
1.38* 
2.81* 
6CH2 
7CH2 
6.76 
7CH2 
eCH2 
7CH2 
1.82 
7CH2 
•yCH 3.24 
5NH2 7.60. 
7CH2 1.69; 
7CH2 1.40, 
3.01, 3.15; 
6.90, 6.79 
•yCH 3.14 
eCH2 6.65 
; eNH2 8.01, 
5CH2 
eNH3 
1.54*; 
7.60 
1.99, 2.22; eCH3 
1.73; 8CH3 0.58* 
8CH3 0.73* 
1.56; 8CH2 
eNH 7.72; T|H 
•yCH2 2.17* 
7CH3 0.80, 0.90 
•yCH2 1.35*; 8CH2 1.52* 
7CH2 1.27*; 8CH2 1.46* 
8NH2 7.57, 6.99 
7.28, 7.12 
"These chemical shifts were determined at pH 6.5 with a peptide 
concentration of approximately 2 mM. The chemical shifts cited are 
relative to DSS which was set to 0 ppm. An asterix (*) indicates 
degenerate resonances. 
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Table 2 {continued) Table 2 {continued) 
Intraresidue and [side-chain-side-chain] Group definitions 
11 HN 
11 HB 
11 HD 
11 HD 
11 HD 
12 HM 
12 HM 
12 HM 
12 HM 
13 Hri 
13 HB 
13 HD 
13 HG 
13 HB 
13 HG 
13 HD 
14 HG 
14 HG 
14 HG 
14 HA 
14 HG 
14 HB 
15 HN 
16 HG 
17 HM1 
20 HD 
20 HD 
21 NHt 
21 NHt 
Group NOEs 
X5 
X5 
X5 
X6 
X7 
X8 
X10 
X9 
X10 
X5 
X16 
X17 
X19 
X19 
X19 
X17 
X8 
12 HM 
12 HM 
11 HB 
11 HA 
11 HN 
16 HG 
13 HB 
15 HM 
11 HN 
17 HM1 
10 HN 
13 HN 
17 HM 
14 HN 
14 HN 
14 HN 
17 HM1 
17 HN 
18 HN 
17 HM 
15 HN 
15 HN 
17 HM 
17 HM 
21 HM2 
16 HB 
17 HA 
19 HA 
20 HA 
XI 
X2 
X3 
XI 
XI 
X4 
X l l 
X14 
X13 
XI 
X15 
X18 
X20 
X21 
X22 
X26 
X27 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
3.7 
3.7 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
5.0. 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
5.0, 2.0 
3. Results and discussion 
3.1. Conantokin-T has a high helical content in the absence of 
metal binding 
Previous investigations demonstrated that apo-con-T is sig-
nificantly helical in aqueous solution and at 25°C [5,6]. Low-
ering the temperature to 5°C resulted in an increase of helical 
content to approximately 55%, as determined by CD. This 
value is an under estimation of the true helical content as 
the result of a contribution by tyrosine to the CD signal at 
222 nm [22]. The proton resonance linewidths and chemical 
shifts remained constant over approximately 0.5 to 4.0 mM, 
suggesting that the peptide remains monomeric in aqueous 
solution at the concentration (2 mM) used for NMR analysis. 
This result is consistent with our previous studies using CD 
and gel permeation chromatography [6], indicating that struc-
ture formation with apo-con-T is an intrinsic property of the 
XI 
X2 
X3 
X4 
X5 
X6 
X7 
X8 
X9 
X10 
X l l 
X12 
X13 
X14 
X15 
X16 
X17 
X18 
X19 
X20 
X21 
X22 
X23 
X24 
X25 
X26 
X27 
7 HB, 
7 HG, 
7 HD, 
13 HB 
11 HD 
10 HG 
11 HB2 
16 HB, 
6HG 
4HG, 
13 HE, 
10 HG 
2 HG, 
7 HB, 
15 HM, 
16 HB 
17 HM1 
13 HA, 
14 HG 
13 HB, 
13 HD, 
13 HG, 
11 HB 
14HB1, 
16 HG 
18 HG, 
18 HB, 
13 HB 
13 HG 
13 HD 
17 HB 
5 HB 
7 HN 
4 HB 
9HG 
18 HG 
14 HA 
18 HB 
18 HD 
18 HG 
10HB1 
15 HM 
19 HB 
monomeric peptide. The significant helical content of this 
peptide may be rationalized by an inspection of the primary 
sequence of the con-T peptide (Fig. 2). Reminiscent of a de 
novo designed alanine-based peptide, each charged residue 
has at least one oppositely charged side-chain to interact 
with at positions (z, i+3 or i, i+4) that are favored in helical 
conformations [23]. Likewise, the majority of the hydrophobic 
residues are also appropriately spaced, such that stabilizing 
contacts may be formed [7,24]. The presence of negatively 
charged residues at the N-terminus (Glu2-Gla3-Gla4) and pos-
itively charged amino acids at the C-terminus (Lys18-Lys19) 
could provide stabilization of the helix macro-dipole. The po-
tential to form many of the known helix-stabilizing interac-
tions therefore exist in this peptide and extend from the N- to 
C-termini. 
Conformations of apo-con-T can be examined on a residue-
specific basis by use of NMR after the assignment of all the 
proton resonances. The chemical shifts of the H a protons are 
generally dependent on molecular conformation, composition 
and environment. But after subtracting the values estimated 
for a random-coil state, the resulting differences (or conforma-
tional shifts) are strongly related to the backbone conforma-
tion or the secondary structure, independent of the sequence 
of the peptide [25,26]. Upfield shifts of 0.1 ppm or greater for 
the H a resonances, when compared to the random-coil values, 
are indicative of a helical structure, if this occurs over four or 
more adjacent residues. Fig. 3 shows the conformational shifts 
of the H a proton resonances for every residue of the con-T 
peptide. The random-coil value of 4.18 ppm for the Gla res-
idue was determined from the NMR spectra of con-T in the 
presence of 6 M urea. A larger than 0.2 ppm upfield shift for 
all the H01 protons indicates that apo-con-T assumes a well-
folded helical structure from Glu2 all the way to Ala21, the 
end of the peptide. In addition, con-T has strong sequential 
S.E. Warder et al.lFEBS Letters 411 (1997) 19-26 23 
C-H-D C-H-D 
F IP 
G-E-y-y-Y-Q-K-M-L-y-N-L-R-y-A-E-V-K-K-N-A-NH2 
IP 
CAP SB 
P 
IP 
Fig. 2. The amino acid sequence of the conantokin-T peptide. Potential side-chain interactions are indicated on the solid line connecting each 
pair of residues. The following abbreviations are used: IP, ion pair; SB, salt-bridge; H, hydrophobic interaction; CAP, favorable capping resi-
due; CHD, favorable charge-helix-dipole interaction. 
backbone NH-NH NOEs [CINNO, »+l)] and exhibits many 
characteristic medium-range backbone-backbone IcWO', *+3)] 
and backbone-side-chain [dap(7, /+3)] NOE contacts through-
out the peptide (Fig. 4). Most of these NOEs also exist in the 
NOESY spectra acquired at higher temperatures, as long as 
the involved protons have well-resolved resonances. The ma-
jority of [daN(;, /+1)] NOEs (Fig. 5) were found to be signifi-
cantly weaker than the corresponding [CINNO', *+l)] crosspeaks, 
consistent with a high degree of helical structure. Further-
more, three-bond coupling constants, JaN, between the H
a 
and the NH protons are around 5 Hz for residues with 
well-resolved H a-NH correlation peaks (e.g., residues Gla3, 
Lys7, Asn11, and Val17) and the backbone NH protons 
showed very small temperature-induced upfield shifts of less 
than 4 ppm/K and even increased (downfield-shifted) chemical 
shifts for some residues (data not shown). All these NMR 
parameters indicate that apo conantokin-T is almost entirely 
helical in aqueous solution with very little population of addi-
tional conformations. In addition, the peptide may be strongly 
a-helical since the intensities of the [daN(/, z'+2)] NOEs (Fig. 4) 
are comparable with those of the [dawO', ?+4)] NOEs and are 
much weaker than those of the [dKN0, «+3)] NOEs. 
3.2. Apo-con-T has extensive side-chain NOE contacts 
In addition to the multitude of backbone NOEs, there are 
also many NOE connectivities (Table 2) between the side-
chain protons of the potential contact residues in a helical 
conformation (Fig. 2). For example, the aromatic ring pro-
tons of Tyr5 exhibit strong NOEs to both the methyl protons 
of residues Met8 and Leu9. In addition, the methyl protons of 
residues Met8 and Leu9 have NOE interactions with the meth-
yl protons of Leu12. These side-chain NOEs indicate that 
there must be a well-defined hydrophobic cluster between res-
idues Tyr5, Leu9, Met8, and Leu12 for apo-conantokin-T in 
solution. This hydrophobic cluster remains over the temper-
ature range of 5-25°C since almost all of the NOEs are still 
observed in the respective NOESY spectra (not shown). More 
strikingly, the side-chain NOEs between residues Tyr5, Leu9, 
Met8, and Leu12 persist in the presence of 6 M urea, indicat-
ing that the four hydrophobic residues remain in contact even 
under unfolding conditions. 
Apart from NOEs among the side chains of hydrophobic 
residues, the guanidino protons of Arg13 (at 6.90 and 6.79 
ppm, Table 1) also make NOE contacts to a methyl group 
of residue Val17 and to a (3H proton of Gla10 (Fig. 1). The 
same Val17 methyl group displays an NOE connectivity to the 
y-proton of Gla14 (Table 2). There are also various Arg13/ 
Gla14 side-chain NOE contacts. Contacts involving the side-
chain amide protons have also been characterized for the con-
antokin-T peptide. In particular, the side-chain amide protons 
of Gin6 are adjacent to the y-hydrogen of Gla10 and to the 
methyl groups of Leu9. The Asn20 side-chain amide interacts 
with the backbone, as indicated by an NOE contact with the 
H01 proton of Val17. The terminal amide proton is in spatial 
proximity to the alpha hydrogens of Lys19 and Asn20. The 
observation of relatively sharp Arg13 guanidino protons are 
especially noteworthy because they are usually very broad as a 
result of rapid exchange with solvent water protons [27]. In 
addition, the presence of NOEs to the side chain of Arg13 
indicates that interactions involving this residue may be very 
significant in the conantokin-T peptide. 
3.3. The a-helical structure of apo-conantokin T in solution 
The structure of apo-con-T was generated from a total of 
167 distance constraints (Table 2) derived from 12 intraresi-
due, 70 sequential and 85 medium-range (/, i+2, i, z+3, and i, 
i+4) NOEs. Initially five-hundred structures were generated by 
distance geometry calculations. Fig. 6 shows a cluster of 10 
converged structures after Monte Carlo energy minimization 
with RMSD values of 0.40 and 0.77 A for the backbone and 
all the heavy atoms, respectively. Clearly, the backbone of 
o.o 
M L Gla N 
Residue 
Fig. 3. Chemical shift index for the Ha-proton resonances of con-T 
in 90% aqueous (10 mM sodium borate/100 mM NaCl)/10% D20, 
pH 6.5, at 5°C. The values for each residue were calculated through 
subtraction of the corresponding random coil chemical shift value 
(Wishart et al, 1995) from the measured value. The random coil val-
ue for the Gla residue was estimated as 4.18 ppm (see the text). 
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Fig. 4. Summary of the sequential and interresidue NOEs observed for con-T at 5°C, pH 6.5. An asterix indicates that the assignment of an 
observed cross peak was ambiguous due to resonance overlaps. The height of the bar provides a qualitative measure of the intensities of the 
NOEs in the NOESY (150 or 250 ms mixing time) spectrum of con-T. Included in this figure are a few medium-range NOEs that are degener-
ate or partially overlapped at 5°C, but that were resolved and verified at higher temperatures. 
apo-con-T is a particularly well-defined oc-helix with almost 
no fraying at both the N- and C-terminal ends of the helix. 
The well-folded a-helical conformation of apo-conantokin-T 
is therefore in contrast to the structures of other monomeric 
helices where end fraying was still observed even with opti-
mized capping interactions [7,28]. The conantokin-T helix also 
has well-defined side-chain conformations (Fig. 6), apparently 
owing to the presence of many side-chain NOE interactions 
(Table 2). 
The three-dimensional structure of apo-conantokin-T has a 
unique character with the hydrophobic side chains of Tyr5, 
Met8, Leu9, and Leu12 grouped together on one face of the 
molecule together with the side chain of Glu2 and the Glu16-
Lys19 ion-pair (Fig. 6). The opposite face is highly charged 
3.6 
3.8 
4.0- — Y 3 
ppm 
4.2-
4.4 
4.6 
V17 
Nil 
N11/L12 
' 0 Q g > (3 
N20 
8.5 8.3 8.1 7.9 7.7 
ppm 
Fig. 5. NH-Ha region of a 250 ms mixing time NOESY spectrum of con-T in 90% aqueous (10 mM sodium borate/100 mM NaCl)/10% 2H20, 
pH 6.5, at 5°C. Glu2 and Gla3 are shifted downfield at 9.13 and 9.21 ppm, respectively. 
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Fig. 6. A stereoview of a cluster of 10 low energy conformations of con-T derived from distance geometry calculations followed by Monte Car-
lo energy minimization. The structures were superimposed using the Ca atoms of all the residues (Gly^Ala21). Positively charged side-chains 
(Lys7, Arg13, Lys18, and Lys19) are colored in red, the Gla residues (Gla3, Gla4, Gla10 and Gla14) are in blue, Gin6 is magenta, and the hydro-
phobic cluster (Tyr5, Met8, Leu9 and Leu12) is shown in green. The backbone conformations of all the structures are in the a-helical region 
(<|>~— 60, \|/~— 40) for all residues from Gla3 to Ala21. The well-defined structure of the apo-con-T a-helix is a direct consequence of the 
many NOE contacts among the amino acid side chains (Table 2), in addition to the backbone NOE connectivities (Fig. 4). 
and consists of a potential Gla3-Lys7 ion pair, a Gla10-Arg13-
Gla14-Lys18 electrostatic network and a Gln6-Gla10 hydrogen 
bonding contact. The interaction between Gla10 and Arg13 is 
mediated in addition by a hydrogen bond between one of the 
carboxylate groups of Gla10 and the eNH proton of Arg13, 
presumably responsible for an downfleld shifted NH proton 
resonance for the Arg13 side chain (Table 1). These electro-
static interactions and hydrogen bonding contacts are the di-
rect consequence of the NOE distance constraints since Arg 
and Lys were treated as neutral and the hydrogen-bonding 
potential of the Gin, Asn, Arg and Lys side chains was elim-
inated during the calculation of the structures (see the Section 
2). 
At the beginning of the helix, the positively-charged free N-
terminus appears to be in contact with the negatively-charged 
side chain of Gla4 (Fig. 6). The three exposed backbone NH 
groups of residues Glu2, Gla3 and Gla4 seem to have strong 
interactions with one of the carboxylate groups of Gla4, mak-
ing Gla4 the apparent capping residue with side-chain to 
main-chain hydrogen bonding interactions. In all, the nega-
tively charged side chains of residues Glu2, Gla3 and Gla4 face 
away from one another, apparently to minimize electrostatic 
repulsion among the five negative charges (Glu2, — 1; Gla3, 
and Gla4, —2). On the C-terminal end of the helix, the ex-
posed carbonyl groups appear to be capped by the side-chain 
amides of Asn20 and by the amide group of the last residue 
Ala21, which presumably minimizes the fraying of the helix 
through hydrogen bonding interactions. 
Within the hydrophobic cluster, Tyr5 and Leu12 appear not 
to be in direct contact but are positioned on opposite sides of 
the Met8/Leu9 interaction. The large non-polar surface area of 
Tyr5 seems to accommodate both a sulfur-containing side 
chain of residue Met8, as well as the aliphatic side chain of 
residue Leu9. Although quantitation of these interactions was 
not yet attempted, stabilization of the helical conformation by 
these hydrophobic residues must be significant since the hy-
drophobic contacts persist even in the presence of 6 M urea. 
The arrangement of the polar side chains in conantokin-T is 
particularly interesting: residues Gla10 and Gla14 are im-
mersed in between residues Gin6, Arg13 and Lys18 in the fol-
lowing array of electrostatic/hydrogen-bonding interactions: 
Gln6-Gla10 followed by Gla10-Arg13 followed by Arg13-Gla14 
and followed by Gla14-Lys18 (Fig. 6). The Gln6-Gla10 and 
Arg13-Gla14 interactions appear to be particularly strong 
with close spatial proximities while residue Arg13 in addition 
serves to link the two pairs together. In addition to potential 
charge-helix dipole interactions, both the negatively charged 
Glu2, Gla3 and Gla4 and the positively-charged Lys18 and 
Lys19 serve specific structure roles in the maintenance of the 
helical conformation of the apo peptide in solution. 
3.4. Implications for the biological activities of conantokin 
peptides 
No clear relationship has yet been established between the 
degree of helicity and the binding potency in terms of the 
biological functions of the con-G/con-T peptides [1,3, 
5,29,30]. Regardless, our studies demonstrated that the oc-
helical conformation is an intrinsic property of the conan-
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tokin-T peptide independent of the binding of metal ions. The 
well-folded nature of the apo-con-T helix (Fig. 6) also implies 
the importance of the helical structure for the biological ac-
tivities, since binding-induced unfolding of an a-helix with 
many stabilizing interactions (Fig. 6) would be energetically 
unfavorable and at the expense of a tremendously reduced 
binding affinity. Assuming a helical structure for the bioactive 
conformation, the precise spatial dispositions of the amino 
acid side chains would be more important than those of the 
peptide backbone for binding interactions with the receptor. 
A receptor-bound helical structure of the conantokin peptides 
such as that shown in Fig. 6 also accounts for the observation 
that the binding potency is strongly dependent on the types of 
amino acid side chains in a few locations of the peptide se-
quence [29,30]. The binding of divalent metal ions to con-T 
presumably induces conformational changes in the side chains 
of the amino acids required for optimal interactions with the 
receptor protein. Indeed, preliminary NMR results indicate 
that calcium binding to the con-T peptide results in significant 
changes only in the orientations of a few side chains with well-
defined helical conformations for all amino acid residues (un-
published observations). 
In summary, the presence of many helix stabilizing interac-
tions in apo-conantokin-T confers its ability to exist as a 
highly structured molecule in aqueous solution. The solution 
structure of apo-con-T is essential for characterizing the con-
formational changes induced by metal binding and for devel-
oping a more detailed understanding of conantokin peptide 
structure-function relationships. This study also provided fur-
ther evidence for hydrophobic, electrostatic and hydrogen-
bonding interactions that stabilize an isolated a-helix in sol-
ution. Similar conclusions have been reached on the basis of 
the solution conformations of con-G and con-T reported in a 
recent study independent of this work [31]. Our results indi-
cate that apo-con-T has a well-defined oc-helical structure even 
to the positions of many amino acid side chains (Fig. 6). 
Therefore, there may be less changes in the conformation of 
the conantokin-T peptide upon the binding of divalent metal 
ions as one may infer from a mixture of a- and 3io-helices 
with distorted backbone conformations determined for apo-
con-T in the previous NMR study [31]. 
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